A detailed history of Smithfield Trust CO transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Smithfield Trust CO holds 606 shares of MDXG stock, worth $5,514. This represents 0.0% of its overall portfolio holdings.

Number of Shares
606
Previous 606 -0.0%
Holding current value
$5,514
Previous $4,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$6.16 - $8.08 $702 - $921
-114 Reduced 15.83%
606 $4,000
Q4 2022

Feb 13, 2023

SELL
$2.63 - $3.45 $44 - $58
-17 Reduced 2.31%
720 $2,000
Q1 2022

May 16, 2022

BUY
$4.27 - $6.27 $3,146 - $4,620
737 New
737 $3,000
Q1 2018

May 10, 2018

SELL
$6.69 - $17.96 $635 - $1,706
-95 Closed
0 $0
Q4 2017

Feb 02, 2018

BUY
$10.87 - $13.9 $1,032 - $1,320
95
95 $1,000

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $1.03B
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Smithfield Trust CO Portfolio

Follow Smithfield Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smithfield Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Smithfield Trust CO with notifications on news.